🟢 90/100

This product looks safe

  • Contains proprietary blend — exact ingredient amounts not disclosed
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

ℹ️ Contains proprietary blend — exact ingredient amounts not disclosed

Label Data

1 Capsule(s) Serving Size
100 Servings
Botanical Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

Proprietary Blend
291 mg

Other Ingredients

Capsule

Label Claims — Verification

All Other
Structure/Function
All Other (99% of products) Structure/Function (67% of products)

Target Groups

Adult (18 - 50 Years) Kosher

Product Information

📋 Directions for Use

Recommended Use: Take 1 capsule daily with a meal.

⚠️ Warnings & Precautions

Pregnant or lactating women should consult their health care professional prior to taking this supplement.

Do not use if inner seal is missing or damaged.

🧪 Formulation Notes

Each capsule contains a guaranteed 800 mcg of parthenolide, one of a group of sesquiterpene lactones, an active component of feverfew.

Ko Pareve (Kosher)

Nervous system support Concentrated Supports the cerebral vascular system

Guaranteed pure

Additional Information

Bottle made from 100% post consumer recycled material. We are committed to you and our planet. Scan to learn more.

Ko Pareve (Kosher)

New look! Same great product

Product Details

UPC / SKU 0 99904 00288 3
DSLD Entry Date 2022-10-24
Product Type Botanical
Form Capsule
DSLD ID 278065
Data Updated 2026-04-11

Research Evidence

10 Research Sources
48 Avg Quality Score
4 Systematic Review
4 Rct
1 Meta Analysis
1 Cochrane Review
B Feverfew for preventing migraine.
Cochrane Review The Cochrane database of systematic reviews
C Feverfew for preventing migraine
Systematic Review The Cochrane database of systematic reviews 2004
C Feverfew for preventing migraine
Systematic Review The Cochrane database of systematic reviews 2000
C Randomised double-blind placebo-controlled trial of feverfew in migraine prevention
Rct Lancet (London, England) 1988
C Feverfew for migraine prophylaxis: a systematic review
Systematic Review Journal of dietary supplements 2009
C Tanacetum parthenium and Salix alba (Mig-RL) combination in migraine prophylaxis: a prospective, open-label study
Meta Analysis Clinical drug investigation 2006
C The combined effect of acupuncture and Tanacetum parthenium on quality of life in women with headache: randomised study
Rct Acupuncture in medicine : journal of the British Medical Acupuncture Society 2012
C A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial
Rct Headache 2004
C Feverfew as a preventive treatment for migraine: a systematic review
Systematic Review Cephalalgia : an international journal of headache 1998
D Efficacy of feverfew as prophylactic treatment of migraine
Rct British medical journal (Clinical research ed.) 1985
View all evidence for Feverfew →

Compare Similar Products

View all Feverfew products →